Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
J Appl Toxicol ; 32(10): 783-9, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21500234

RESUMEN

Reporter gene assays are commonly used in applied toxicology to measure the transcription of genes involved in toxic responses. In these reporter gene assays, transgenic cells are used, which contain a promoter-operator region of a gene of interest fused to a reporter gene. The transcription of the gene of interest can be measured by the detection of the reporter protein. Chloramphenicol acetyl transferase (CAT) is frequently used as a reporter protein in mammalian reporter gene assays. Although CAT can be measured by different detection systems, like enzymatic and immune assays, most of these tests are expensive, time-consuming and labor-intensive. The excellent characteristics of phages, like their high affinity and specificity, their fast, cheap and animal-friendly manufacturing process with low batch-to-batch variations and their stability, make them appropriate as alternatives for antibodies in detection assays. Therefore, in this study single-chain variable fragment (scFv) phages were selected with affinity for CAT. Several scFv phages were selected that showed affinity towards CAT in a screening ELISA. Surface plasmon resonance analyses showed that the tested scFv phages have an affinity for CAT with a dissociation constant (K(d)) around 1 µM. The selected scFv phages in this study could be used as capture elements in a highly sensitive sandwich ELISA to detect CAT concentration as low as 0.1 ng ml⁻¹ or 4 pM. This low detection limit demonstrates the potential of the scFv phages as an alternative for capturing antibodies in a highly sensitive detection test to measure CAT concentrations in reporter gene assays.


Asunto(s)
Especificidad de Anticuerpos , Bacteriófagos/efectos de los fármacos , Cloranfenicol O-Acetiltransferasa/metabolismo , Genes Reporteros , Anticuerpos de Cadena Única/metabolismo , Toxicología/métodos , Transcripción Genética , Afinidad de Anticuerpos , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Bacteriófagos/metabolismo , Cloranfenicol O-Acetiltransferasa/antagonistas & inhibidores , Cloranfenicol O-Acetiltransferasa/genética , Ensayo de Inmunoadsorción Enzimática/métodos , Biblioteca de Genes , Genes Reporteros/efectos de los fármacos , Humanos , Límite de Detección , Regiones Operadoras Genéticas/efectos de los fármacos , Regiones Promotoras Genéticas/efectos de los fármacos , Análisis por Matrices de Proteínas , Proteínas Recombinantes/antagonistas & inhibidores , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Anticuerpos de Cadena Única/química , Anticuerpos de Cadena Única/genética , Solubilidad , Resonancia por Plasmón de Superficie , Transcripción Genética/efectos de los fármacos
2.
Biosci Biotechnol Biochem ; 72(9): 2403-10, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18776694

RESUMEN

The mercury resistance module of Bacillus transposon TnMERI1 is regulated by three operator/promoter regions (O/P merB3, O/P merR1, and O/P merR2) and two regulatory proteins (MerR1 and MerR2) encoded by the module itself. To clarify the roles of MerR1 and MerR2 in the regulatory mechanism, both proteins were overexpressed and purified. MerR1 bound the regulatory regions O/P merB3 and O/P merR1, with a preference for O/P merB3 as measured on in vitro gel shift assays. However, MerR2 bound O/P merR2, as revealed by gel shift and restriction endonuclease protection assays. The transcriptional start sites of O/P merB3 and O/P merR2 were determined by rapid amplification of 5'-cDNA ends (5'-RACE) in the TnMERI1 original host, Bacillus megaterium strain MB1. Real-time reverse transcription polymerase chain reaction (RT-PCR) assays showed that O/P merB3 and O/P merR1 were induced in the presence of Hg2+ but not O/P merR2. It was concluded that MerR1 regulates O/P merB3 and O/P merR1, while MerR2 regulates O/P merR2.


Asunto(s)
Bacillus megaterium/genética , Proteínas Bacterianas/genética , Regulación Bacteriana de la Expresión Génica/efectos de los fármacos , Mercurio/farmacología , Regiones Operadoras Genéticas/efectos de los fármacos , Regiones Promotoras Genéticas/efectos de los fármacos , Bacillus megaterium/metabolismo , Proteínas Bacterianas/aislamiento & purificación , Secuencia de Bases , Elementos Transponibles de ADN/genética , ADN Bacteriano/química , ADN Bacteriano/genética , Genes Bacterianos/genética , Mercurio/metabolismo , Datos de Secuencia Molecular , Plásmidos
3.
J Mol Biol ; 196(3): 505-16, 1987 Aug 05.
Artículo en Inglés | MEDLINE | ID: mdl-2824783

RESUMEN

The Tn3 resolvase requires that the two recombination (res) sites be aligned as direct repeats on the same molecule for efficient recombination to occur. To test whether resolvase must contact the DNA between res sites as predicted by tracking models, we have determined the sensitivity of recombination to protein diffusion blockades. Recombination between two res sites is unaffected either by lac repressor or bacteriophage T7 RNA polymerase being bound between them. Yet recombination is inhibited by lac repressor if the res site is bounded by a lac operator on both sides. We demonstrate that lac repressor will bind to more than one DNA site under the conditions used to assay recombination. This result suggests that lac repressor can inhibit resolvase by forming a DNA loop that isolates a res site topologically. These results do not support a tracking model for resolvase but suggest that the structure and topology of the DNA substrate is important in the formation of a synapse between res sites.


Asunto(s)
Nucleotidiltransferasas/antagonistas & inhibidores , Regiones Operadoras Genéticas/efectos de los fármacos , Recombinación Genética/efectos de los fármacos , Proteínas Represoras/farmacología , Factores de Transcripción/farmacología , Sitios de Unión , ADN/metabolismo , Isopropil Tiogalactósido/farmacología , Conformación de Ácido Nucleico , Plásmidos , Transposasas
4.
J Mol Biol ; 247(3): 396-403, 1995 Mar 31.
Artículo en Inglés | MEDLINE | ID: mdl-7714896

RESUMEN

Tetrameric Lac repressor achieves cooperative repression by binding simultaneously to O1 and to one of the auxiliary operators O2 or O3, thereby forcing the intervening DNA into a loop. Dimeric Lac repressor is not able to form DNA loops and consequently shows no cooperative repression. We constructed a dimeric Lac repressor mutant which exhibits increased repression to the lac operon that does not depend on specific operator-repressor-operator loops. This Lac repressor carries a synthetic tail of basic residues attached to its C terminus. With this construct, we observe an increase of the in vivo repression upon addition of auxiliary lac operators to a chromosomal lac operon controlled by O1. This suggests that the basic tail enables dimeric Lac repressor to enhance its repression by additional non-specific DNA contacts.


Asunto(s)
Regiones Operadoras Genéticas/efectos de los fármacos , Conformación Proteica , Proteínas Represoras/química , Secuencia de Aminoácidos , ADN Bacteriano/metabolismo , Escherichia coli/genética , Escherichia coli/metabolismo , Operón Lac/efectos de los fármacos , Datos de Secuencia Molecular , Conformación de Ácido Nucleico , Unión Proteica , Ingeniería de Proteínas , Proteínas Recombinantes de Fusión/química , Proteínas Recombinantes de Fusión/metabolismo , Proteínas Recombinantes de Fusión/farmacología , Proteínas Represoras/metabolismo , Proteínas Represoras/farmacología , Relación Estructura-Actividad
5.
DNA Cell Biol ; 14(8): 665-71, 1995 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-7646813

RESUMEN

In this work, we have studied the activity of a tetracycline modulatable trans-activator (tTA) generated by fusing the DNA binding domain of the tetracycline repressor to the trans-activation domain of the Herpes simplex virus protein 16 (HSV VP16) (plasmid pUHD15-1Neo). In the three different cell lines studied (HTC, rat hepatoma; T47D, human breast cancer; SK-N-BE, human neuroblastoma), the expression of the luciferase gene under the control of a tetracycline operator sequence (plasmid pUHC13-3) was used as a control of the incorporation and the functionality of the trans-activator. Clones selected from these cells responded in a time and dose-dependent manner to the withdrawal of tetracycline. In all these clones, the tTA trans-activator not only modulates the activity of the luciferase gene, but also modulates the activity of a number of endogenous proteins, including C/EBP beta, the glucocorticoid receptor (GR), and SP1. In the transfected cells, the level of these transcription factors was strongly inhibited in the presence of tetracycline and was highly increased after tetracycline removal. Electrophoresis mobility shift assay (EMSA) and footprint experiments proved that the induced proteins are perfectly efficient in binding the DNA. Their transcriptional activity was also determined. In HTC/A9 cells, the level of the chloramphenicol acetyltransferase (CAT) expression driven by the promoter of the alpha 1-glycoprotein (AGP) gene was strongly enhanced at 72-84 hr following removal of tetracycline from the growth media. The accumulation of the endogenous AGP mRNA also increased at 84 hr. In the T47D/TA11 and SK-N-BE/C2.6 cells, a general activation of protein synthesis was also evidenced.


Asunto(s)
Vectores Genéticos/genética , Proteína Vmw65 de Virus del Herpes Simple/metabolismo , Proteínas Represoras/metabolismo , Tetraciclina/farmacología , Transactivadores/metabolismo , Animales , Secuencia de Bases , Citomegalovirus/genética , ADN/metabolismo , Regulación de la Expresión Génica/efectos de los fármacos , Proteína Vmw65 de Virus del Herpes Simple/genética , Humanos , Luciferasas/biosíntesis , Luciferasas/genética , Datos de Secuencia Molecular , Regiones Operadoras Genéticas/efectos de los fármacos , Regiones Promotoras Genéticas/genética , ARN Mensajero/biosíntesis , Ratas , Receptores de Estradiol/genética , Receptores de Glucocorticoides/genética , Receptores de Glucocorticoides/metabolismo , Proteínas Recombinantes de Fusión/biosíntesis , Proteínas Recombinantes de Fusión/metabolismo , Proteínas Represoras/genética , Transactivadores/genética , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Células Tumorales Cultivadas
6.
Biochem J ; 250(3): 925-8, 1988 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-3291858

RESUMEN

The interaction of the trp repressor from Escherichia coli with a 20 bp fragment of DNA (CGTACTGATT.AATCAGTACG) corresponding to a mutant trp operator was studied by c.d. in the presence and absence of the co-repressor, L-tryptophan, and as a function of the concentration of K+ and Na+ ions. The affinity of the repressor for the mutant operator in the presence of tryptophan is about three orders of magnitude lower than the wild-type sequence. Binding in the absence of tryptophan is about 100-fold weaker than to the wild-type. The dependence of the dissociation constant on the concentration of K+ or Na+ is weak [d(log Ks)/d(log[M+]) = 2.5], and independent of the cation, indicating that electrostatic interactions are not as important for this repressor as for others.


Asunto(s)
Proteínas Bacterianas , Escherichia coli/genética , Regiones Operadoras Genéticas , Proteínas Represoras/genética , Factores de Transcripción/genética , Secuencia de Bases , Dicroismo Circular , ADN Bacteriano/genética , Mutación , Regiones Operadoras Genéticas/efectos de los fármacos , Potasio/farmacología , Unión Proteica/efectos de los fármacos , Sodio/farmacología , Triptófano/farmacología
7.
J Bacteriol ; 181(6): 1719-27, 1999 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10074062

RESUMEN

The deoR gene located just upstream the dra-nupC-pdp operon of Bacillus subtilis encodes the DeoR repressor protein that negatively regulates the expression of the operon at the level of transcription. The control region upstream of the operon was mapped by the use of transcriptional lacZ fusions. It was shown that all of the cis-acting elements, which were necessary for full DeoR regulation of the operon, were included in a 141-bp sequence just upstream of dra. The increased copy number of this control region resulted in titration of the DeoR molecules of the cell. By using mutagenic PCR and site-directed mutagenesis techniques, a palindromic sequence located from position -60 to position -43 relative to the transcription start point was identified as a part of the operator site for the binding of DeoR. Furthermore, it was shown that a direct repeat of five nucleotides, which was identical to the 3' half of the palindrome and was located between the -10 and -35 regions of the dra promoter, might function as a half binding site involved in cooperative binding of DeoR to the regulatory region. Binding of DeoR protein to the operator DNA was confirmed by a gel electrophoresis mobility shift assay. Moreover, deoxyribose-5-phosphate was shown to be a likely candidate for the true inducer of the dra-nupC-pdp expression.


Asunto(s)
Bacillus subtilis/genética , Proteínas Bacterianas/genética , Proteínas de Unión al ADN , Proteínas de Transporte de Membrana , Regiones Operadoras Genéticas , Operón , Proteínas Represoras/genética , Aldehído-Liasas/genética , Bacillus subtilis/metabolismo , Secuencia de Bases , Sitios de Unión/genética , Proteínas Portadoras/genética , ADN Bacteriano/genética , ADN Bacteriano/metabolismo , Expresión Génica , Genes Bacterianos , Operón Lac , Datos de Secuencia Molecular , Mutagénesis , Mutagénesis Sitio-Dirigida , Regiones Operadoras Genéticas/efectos de los fármacos , Pentosiltransferasa/genética , Reacción en Cadena de la Polimerasa , Pirimidina Fosforilasas , Ribosamonofosfatos/metabolismo , Ribosamonofosfatos/farmacología , Eliminación de Secuencia
8.
J Bacteriol ; 174(3): 671-81, 1992 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-1346263

RESUMEN

In vivo dimethyl sulfate footprinting of the Bacillus subtilis glnRA regulatory region under repressing and derepressing conditions demonstrated that the GlnR protein, encoded by glnR, interacts with two sites situated within and adjacent to the glnRA promoter. One site, glnRAo1, between positions -40 and -60 relative to the start point of transcription, is a 21-bp symmetrical element that has been identified as essential for glnRA regulation (H. J. Schreier, C. A. Rostkowski, J. F. Nomellini, and K. D. Hirschi, J. Mol. Biol. 220:241-253, 1991). The second site, glnRAo2, is a quasisymmetrical element having partial homology to glnRAo1 and is located within the promoter between positions -17 and -37. The symmetry and extent of modifications observed for each site during repression and derepression indicated that GlnR interacts with the glnRA regulatory region by binding to both sites in approximately the same manner. Experiments using potassium permanganate to probe open complex formation by RNA polymerase demonstrated that transcriptional initiation is inhibited by GlnR. Furthermore, distortion of the DNA helix within glnRAo2 occurred upon GlnR binding. While glutamine synthetase, encoded by glnA, has been implicated in controlling glnRA expression, analyses with dimethyl sulfate and potassium permanganate ruled out a role for glutamine synthetase in directly influencing transcription by binding to operator and promoter regions. Our results suggested that inhibition of transcription from the glnRA promoter involves GlnR occupancy at both glnRAo1 and glnRAo2. In addition, modification of bases within the glnRAo2 operator indicated that control of glnRA expression under nitrogen-limiting (derepressing) conditions included the involvement of a factor(s) other than GlnR.


Asunto(s)
Bacillus subtilis/genética , Proteínas de Unión al ADN/genética , Secuencias Reguladoras de Ácidos Nucleicos/genética , Proteínas Represoras/genética , Secuencia de Bases , Sitios de Unión , Proteínas de Unión al ADN/metabolismo , Regulación Bacteriana de la Expresión Génica , Glutamato-Amoníaco Ligasa/genética , Guanina/química , Metilación , Datos de Secuencia Molecular , Regiones Operadoras Genéticas/efectos de los fármacos , Regiones Operadoras Genéticas/genética , Permanganato de Potasio/farmacología , Regiones Promotoras Genéticas/genética , Pirimidinas/química , Secuencias Reguladoras de Ácidos Nucleicos/efectos de los fármacos , Proteínas Represoras/metabolismo , Ésteres del Ácido Sulfúrico/farmacología
9.
J Biol Chem ; 264(16): 9149-54, 1989 Jun 05.
Artículo en Inglés | MEDLINE | ID: mdl-2656696

RESUMEN

We have employed a filter binding assay to help study the mechanism by which bound L-tryptophan enables the Escherichia coli trp repressor to bind its operators. We have prepared variants of the trp repressor using structural analogues of the natural corepressor, L-tryptophan, and measured the affinity of these variants for a 20-base pair oligonucleotide duplex containing a symmetrical idealization of the trp operator from the E. coli trpEDCBA operon. By normalizing for each analogue's previously determined affinity for the trp aporepressor, we have estimated the extent to which each of the functional groups of bound L-tryptophan contributes to operator affinity. We discuss the likely role of these functional groups in the context of the crystal structures of the inactive, unliganded trp aporepressor, the liganded, active repressor, an inactive pseudorepressor (Pseudorepressors are formed by analogues of L-tryptophan that bind at the tryptophan-binding site but form near isomorphs of the repressor that have poor affinity for operator-DNA.) and the trp repressor/operator complex. We find that the alpha-amino group and an unsubstituted amino (-NH-) nitrogen of L-tryptophan's indole ring are essential for operator affinity. The former properly orients the corepressor and the latter interacts directly with the DNA. The alpha-carboxyl group, on the other hand, greatly enhances but is not essential for operator binding. The alpha-carboxylate's role, which is dependent on the corepressor's orientation in the binding pocket, is apparently to position the guanidinium group of Arg-84 for favorable contacts with the operator's sugar-phosphate backbone.


Asunto(s)
Proteínas Bacterianas/metabolismo , ADN Bacteriano/metabolismo , Escherichia coli/genética , Regiones Operadoras Genéticas/efectos de los fármacos , Proteínas Represoras/metabolismo , Factores de Transcripción/metabolismo , Triptófano/farmacología , Composición de Base , Escherichia coli/efectos de los fármacos , Enlace de Hidrógeno , Cinética , Oligonucleótidos , Conformación Proteica , Estereoisomerismo , Relación Estructura-Actividad , Triptófano/análogos & derivados
10.
Arch Virol ; 143(1): 35-48, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9580095

RESUMEN

To explore the effects BICP0 (a principal transactivator of BHV-1 gene expression) on viral promoter elements, we established a cell line in which the expression of BICP0 is regulated by tetracycline. A hybrid promoter containing reiterated copies of the tet-operator (tet-O) and a minimal herpesviral alpha gene transinducing factor (alpha TIF) responsive element (minimal human cytomegalovirus immediate early promoter) was fused to the BICP0 gene and used to transform a HeLa cell line which expressed a fusion protein consisting of the repressor of the tet-O and the transactivating domain of alpha TIF. Simultaneously, the hygromycin resistance gene was transfected to select cells in media containing either hygromycin alone or both hygromycin and tetracycline. Immunofluorescent assays indicated that BICP0 was synthesised in the transformed cell lines solely upon induction of the gene by tetracycline removal. Only cells which had been kept constantly in medium containing tetracycline were able to synthesise BICP0 upon induction. Induced cell lines transactivated the native BICP0 promoter as well as the herpes simplex virus thymidine kinase promoter and the long terminal repeat sequences of human immunodeficiency virus in a dose dependent manner. These cell lines may help to further explore the functions of BICP0 as well as to investigate the molecular basis of interactions between herpes- and retroviruses.


Asunto(s)
Células HeLa/metabolismo , Inhibidores de la Síntesis de la Proteína/farmacología , Tetraciclina/farmacología , Transactivadores/efectos de los fármacos , Transactivadores/genética , Proteínas Virales/efectos de los fármacos , Proteínas Virales/genética , Línea Celular Transformada/efectos de los fármacos , Línea Celular Transformada/metabolismo , ADN Viral/análisis , ADN Viral/genética , Expresión Génica/efectos de los fármacos , Expresión Génica/genética , Expresión Génica/fisiología , Regulación Viral de la Expresión Génica/efectos de los fármacos , Genes Virales/genética , Duplicado del Terminal Largo de VIH/genética , Herpesvirus Humano 1/enzimología , Herpesvirus Humano 1/genética , Humanos , Regiones Operadoras Genéticas/efectos de los fármacos , Reacción en Cadena de la Polimerasa , Regiones Promotoras Genéticas/genética , Regiones Promotoras Genéticas/fisiología , Proteínas Recombinantes/efectos de los fármacos , Proteínas Recombinantes/genética , Resistencia a la Tetraciclina/genética , Timidina Quinasa/genética , Transactivadores/fisiología , Activación Transcripcional/genética , Activación Transcripcional/fisiología , Transfección/genética , Ubiquitina-Proteína Ligasas , Proteínas Virales/fisiología , Proteínas Estructurales Virales/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA